Prophylactic or therapeutic doses of heparins for COVID-19 infection? A retrospective study

BACKGROUND: Coronavirus disease 19 (COVID-19) is a global outbreak. COVID-19 patients seem to have relevant coagulative abnormalities, even if they are not typical of disseminated intravascular coagulopathy (DIC) of the kind seen in septicaemia. Therefore, anticoagulant therapy with heparins is incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolzetta, Francesco, Maselli, Monica, Formilan, Marino, Busonera, Flavio, Albanese, Paolo, Chiaromanni, Federica, Romano, Antonietta, Veronese, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667217/
https://www.ncbi.nlm.nih.gov/pubmed/33196991
http://dx.doi.org/10.1007/s40520-020-01750-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667217/
https://www.ncbi.nlm.nih.gov/pubmed/33196991
http://dx.doi.org/10.1007/s40520-020-01750-6

Ejemplares similares